Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRAPARIB vs TALAZOPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRAPARIB vs TALAZOPARIB: Safety Overview

Metric NIRAPARIB TALAZOPARIB
Total FAERS Reports 21,634 1,477
Deaths Reported 1,370 278
Death Rate 6.3% 18.8%
Hospitalizations 4,892 553
Average Patient Age 65.7 yrs 60.1 yrs
% Female Patients 98.5% 55.7%
FDA Approval Date Apr 26, 2023 Jun 20, 2023
Manufacturer GlaxoSmithKline LLC Pfizer Laboratories Div Pfizer Inc
Route ORAL ORAL
Marketing Status Discontinued Discontinued